Atlas Trials

Integrative Molecular Characterization Of MiT Family Translocation Renal Cell Carcinomas (IMCOR)

Clinical trial NCT05456074 · UNKNOWN

Trial details

NCT number
NCT05456074
Sponsor
Institut de cancérologie Strasbourg Europe
Status
UNKNOWN
Study type
OBSERVATIONAL
Renal Carcinoma
Start date
2023-01-25
Primary completion
2026-01-25
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.